If approved by the FDA, Darzalex Faspro may be the first treatment for smoldering multiple myeloma as compared to treating the disease once it progresses.
A new study finds that pathogenic germline variants (PGVs) in cancer predisposition genes like BRCA1 and BRCA2 increase the risk of multiple ...
Multiple Myeloma is a type of blood cancer that develops in plasma ... and advanced therapies like blood stem cell ...
J&J’s filing is based on results from the phase 3 AQUILA trial. Among 390 patients with high-risk smoldering multiple myeloma ...
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with ...
Multiple myeloma is the second most common hematologic malignancy, but there is a treatment gap for patients with disease ...
The FDA has granted LBL-034 orphan drug designation for relapsed/refractory multiple myeloma treatment. LBL-034 has received ...
Truist Securities analyst Asthika Goonewardene in an investor note said data for anito-cel—particularly its safety ...
Heidelberg Pharma: Promising New Clinical Data on Lead ADC-Candidate HDP-101 to be Presented at ASH Annual Meeting 2024 ...
Legendary folk singer, Sharda Sinha, aka 'Bihar's Kokila', passed away at 72 due to myeloma on the first day of Chhath Puja.
Multiple sclerosis, a neuroinflammatory disease that affects nearly 3 million people worldwide, causes a loss of myelin, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback